Unmet needs and harm reduction preferences of syringe services program participants: differences by co-use of illicit opioids and methamphetamine.
Humans
Needle-Exchange Programs
/ statistics & numerical data
Harm Reduction
Female
Male
Adult
Methamphetamine
Substance Abuse, Intravenous
/ epidemiology
Opioid-Related Disorders
/ epidemiology
Patient Preference
Middle Aged
Amphetamine-Related Disorders
/ epidemiology
Health Services Needs and Demand
/ statistics & numerical data
Illicit Drugs
Analgesics, Opioid
/ therapeutic use
Co-use
Harm reduction preferences
Injection drug use
Unmet needs
Journal
Harm reduction journal
ISSN: 1477-7517
Titre abrégé: Harm Reduct J
Pays: England
ID NLM: 101153624
Informations de publication
Date de publication:
19 Jun 2024
19 Jun 2024
Historique:
received:
11
03
2024
accepted:
14
06
2024
medline:
19
6
2024
pubmed:
19
6
2024
entrez:
18
6
2024
Statut:
epublish
Résumé
The current fourth wave of the United States opioid overdose epidemic is characterized by the co-use of opioids and stimulants, including illicit opioids and methamphetamine. The co-use of these two drugs, known as "goofballing," is associated with higher risk for several adverse outcomes, including more frequent injections, greater health risks, and higher morbidity. Considering these differences, this unique subpopulation of people who inject drugs (PWID) may also have unique unmet needs and harm reduction preferences. We collected self-reported data from participants (N = 50) of a syringe services program (SSP), including basic needs and harm reduction preferences. Using bivariate analyses, we examined differences between SSP participants who do and do not co-use illicit opioids and methamphetamine. Co-use was defined as reporting the use of both drugs, which may or may not have been used simultaneously. In the overall sample, the mean level of need was highest for bus passes or other transportation, a person who can help you get the services you need, medication for opioid use disorder, and a job or job training. Additionally, all participants reported being either interested or very interested in fentanyl test strips, safe consumption sites, delivery of syringe service supplies, and delivery of naloxone. Those who endorsed co-use had a greater need for food, healthcare, substance use disorder treatment, a support person to help them access needed services, and bus passes or transportation. Unmet needs were prevalent, and the desire for more harm reduction services was high among these PWID. Results also suggest people who co-use illicit opioids and methamphetamine may have the greatest unmet needs and desire for additional harm reduction services.
Sections du résumé
BACKGROUND
BACKGROUND
The current fourth wave of the United States opioid overdose epidemic is characterized by the co-use of opioids and stimulants, including illicit opioids and methamphetamine. The co-use of these two drugs, known as "goofballing," is associated with higher risk for several adverse outcomes, including more frequent injections, greater health risks, and higher morbidity. Considering these differences, this unique subpopulation of people who inject drugs (PWID) may also have unique unmet needs and harm reduction preferences.
METHODS
METHODS
We collected self-reported data from participants (N = 50) of a syringe services program (SSP), including basic needs and harm reduction preferences. Using bivariate analyses, we examined differences between SSP participants who do and do not co-use illicit opioids and methamphetamine. Co-use was defined as reporting the use of both drugs, which may or may not have been used simultaneously.
RESULTS
RESULTS
In the overall sample, the mean level of need was highest for bus passes or other transportation, a person who can help you get the services you need, medication for opioid use disorder, and a job or job training. Additionally, all participants reported being either interested or very interested in fentanyl test strips, safe consumption sites, delivery of syringe service supplies, and delivery of naloxone. Those who endorsed co-use had a greater need for food, healthcare, substance use disorder treatment, a support person to help them access needed services, and bus passes or transportation.
CONCLUSIONS
CONCLUSIONS
Unmet needs were prevalent, and the desire for more harm reduction services was high among these PWID. Results also suggest people who co-use illicit opioids and methamphetamine may have the greatest unmet needs and desire for additional harm reduction services.
Identifiants
pubmed: 38890736
doi: 10.1186/s12954-024-01038-2
pii: 10.1186/s12954-024-01038-2
doi:
Substances chimiques
Methamphetamine
44RAL3456C
Illicit Drugs
0
Analgesics, Opioid
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
119Informations de copyright
© 2024. The Author(s).
Références
Allen ST, O’Rourke A, White RH, Smith KC, Weir B, Lucas GM, Sherman SG, Grieb SM. Barriers and facilitators to PrEP use among people who inject drugs in rural Appalachia: a qualitative study. AIDS Behav. 2020;24(6):1942–50. https://doi.org/10.1007/s10461-019-02767-3 .
doi: 10.1007/s10461-019-02767-3
Al-Tayyib AA, Thiede H, Burt RD, Koester S. Unmet health care needs and hepatitis C infection among persons who inject drugs in Denver and Seattle, 2009. Prev Sci. 2015;16(2):330–40. https://doi.org/10.1007/s11121-014-0500-4 .
doi: 10.1007/s11121-014-0500-4
Ashford RD, Brown AM, Dorney G, McConnell N, Kunzelman J, McDaniel J, Curtis B. Reducing harm and promoting recovery through community-based mutual aid: characterizing those who engage in a hybrid peer recovery community organization. Addict Behav. 2019;98: 106037. https://doi.org/10.1016/j.addbeh.2019.106037 .
doi: 10.1016/j.addbeh.2019.106037
Ashford RD, Curtis B, Brown AM. Peer-delivered harm reduction and recovery support services: initial evaluation from a hybrid recovery community drop-in center and syringe exchange program. Harm Reduct J. 2018;15(1):52. https://doi.org/10.1186/s12954-018-0258-2 .
doi: 10.1186/s12954-018-0258-2
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodol). 1995;57(1):289–300.
doi: 10.1111/j.2517-6161.1995.tb02031.x
Brener L, Caruana T, Broady T, Cama E, Ezard N, Madden A, Treloar C. Addressing injecting related risks among people who inject both opioids and stimulants: findings from an Australian survey of people who inject drugs. Addict Behav Rep. 2022;15: 100398. https://doi.org/10.1016/j.abrep.2021.100398 .
doi: 10.1016/j.abrep.2021.100398
Ciccarone D. Fentanyl in the US heroin supply: a rapidly changing risk environment. Int J Drug Policy. 2017;46:107–11. https://doi.org/10.1016/j.drugpo.2017.06.010 .
doi: 10.1016/j.drugpo.2017.06.010
Ciccarone D. The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy. 2019;71:183–8. https://doi.org/10.1016/j.drugpo.2019.01.010 .
doi: 10.1016/j.drugpo.2019.01.010
Compton WM, Valentino RJ, DuPont RL. Polysubstance use in the U.S. opioid crisis. Mol Psychiatry. 2021;26(1):1. https://doi.org/10.1038/s41380-020-00949-3 .
doi: 10.1038/s41380-020-00949-3
Dai Z, Abate MA, Groth CP, Rucker T, Kraner JC, Mock AR, Smith GS. Fentanyl and other opioid involvement in methamphetamine-related deaths. Am J Drug Alcohol Abuse. 2022;48(2):226–34. https://doi.org/10.1080/00952990.2021.1981919 .
doi: 10.1080/00952990.2021.1981919
Des Jarlais DC, Nugent A, Solberg A, Feelemyer J, Mermin J, Holtzman D. Syringe service programs for persons who inject drugs in urban, suburban, and rural areas—United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(48):1337–41. https://doi.org/10.15585/mmwr.mm6448a3 .
doi: 10.15585/mmwr.mm6448a3
Eddie D, Hoffman L, Vilsaint C, Abry A, Bergman B, Hoeppner B, Weinstein C, Kelly JF. Lived experience in new models of care for substance use disorder: a systematic review of peer recovery support services and recovery coaching. Front Psychol. 2019;10: 458901.
doi: 10.3389/fpsyg.2019.01052
Estadt AT, Miller WC, Kline D, Whitney BM, Young AM, Todd Korthuis P, Stopka TJ, Feinberg J, Zule WA, Pho MT, Friedmann PD, Westergaard RP, Eagen KV, Seaman A, Ma J, Go VF, Lancaster KE. Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities. Int J Drug Policy. 2023. https://doi.org/10.1016/j.drugpo.2023.104222 .
doi: 10.1016/j.drugpo.2023.104222
Estadt AT, White BN, Ricks JM, Lancaster KE, Hepler S, Miller WC, Kline D. The impact of fentanyl on state- and county-level psychostimulant and cocaine overdose death rates by race in Ohio from 2010 to 2020: a time series and spatiotemporal analysis. Harm Reduct J. 2024;21(1):13. https://doi.org/10.1186/s12954-024-00936-9 .
doi: 10.1186/s12954-024-00936-9
Friedman J, Shover CL. Charting the fourth wave: geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010–2021. Addiction. 2023;118(12):2477–85. https://doi.org/10.1111/add.16318 .
doi: 10.1111/add.16318
Glick SN, Klein KS, Tinsley J, Golden MR. Increasing Heroin-Methamphetamine (Goofball) use and related morbidity among Seattle area people who inject drugs. Am J Addict. 2021;30(2):183–91. https://doi.org/10.1111/ajad.13115 .
doi: 10.1111/ajad.13115
Godkhindi P, Nussey L, O’Shea T. “They’re causing more harm than good”: a qualitative study exploring racism in harm reduction through the experiences of racialized people who use drugs. Harm Reduct J. 2022;19(1):96. https://doi.org/10.1186/s12954-022-00672-y .
doi: 10.1186/s12954-022-00672-y
Hassan R, Roland KB, Hernandez B, Goldman L, Evans KN, Gaul Z, Agnew-Brune C, Buchacz K, Fukuda HD. A qualitative study of service engagement and unmet needs among unstably housed people who inject drugs in Massachusetts. J Subst Abuse Treat. 2022;138: 108722. https://doi.org/10.1016/j.jsat.2022.108722 .
doi: 10.1016/j.jsat.2022.108722
Hazani HM, Naina Mohamed I, Muzaimi M, Mohamed W, Yahaya MF, Teoh SL, Pakri Mohamed RM, Mohamad Isa MF, Abdulrahman SM, Ramadah R, Kamaluddin MR, Kumar J. Goofballing of opioid and methamphetamine: the science behind the deadly cocktail. Front Pharmacol. 2022;13: 859563. https://doi.org/10.3389/fphar.2022.859563 .
doi: 10.3389/fphar.2022.859563
Hedegaard H, Miniño AM, Warner M. Co-involvement of opioids in drug overdose deaths involving cocaine and psychostimulants. NCHS Data Brief. 2021;406:1–8.
Hoopsick RA, Andrew Yockey R. Methamphetamine-related mortality in the United States: co-involvement of heroin and fentanyl, 1999–2021. Am J Public Health. 2023;113(4):416–9. https://doi.org/10.2105/AJPH.2022.307212 .
doi: 10.2105/AJPH.2022.307212
Jenkins RA. The fourth wave of the US opioid epidemic and its implications for the rural US: a federal perspective. Prev Med. 2021;152(Pt 2): 106541. https://doi.org/10.1016/j.ypmed.2021.106541 .
doi: 10.1016/j.ypmed.2021.106541
Kandel DB, Huang F-Y, Davies M. Comorbidity between patterns of substance use dependence and psychiatric syndromes. Drug Alcohol Depend. 2001;64(2):233–41. https://doi.org/10.1016/S0376-8716(01)00126-0 .
doi: 10.1016/S0376-8716(01)00126-0
Kawasaki S, Francis E, Mills S, Buchberger G, Hogentogler R, Kraschnewski J. Multi-model implementation of evidence-based care in the treatment of opioid use disorder in Pennsylvania. J Subst Abuse Treat. 2019;106:58–64. https://doi.org/10.1016/j.jsat.2019.08.016 .
doi: 10.1016/j.jsat.2019.08.016
Kline D, Bunting AM, Hepler SA, Rivera-Aguirre A, Krawczyk N, Cerda M. State-level history of overdose deaths involving stimulants in the United States, 1999–2020. Am J Public Health. 2023;113(9):991–9. https://doi.org/10.2105/ajph.2023.307337 .
doi: 10.2105/ajph.2023.307337
Korthuis PT, Cook RR, Foot CA, Leichtling G, Tsui JI, Stopka TJ, Leahy J, Jenkins WD, Baker R, Chan B, Crane HM, Cooper HL, Feinberg J, Zule WA, Go VF, Estadt AT, Nance RM, Smith GS, Westergaard RP, Young AM. Association of methamphetamine and opioid use with nonfatal overdose in rural communities. JAMA Netw Open. 2022;5(8): e2226544. https://doi.org/10.1001/jamanetworkopen.2022.26544 .
doi: 10.1001/jamanetworkopen.2022.26544
Mallama CA, Trinidad JP, Swain RS, Zhao Y, Woods C, McAninch JK. A comparison of opioid-involved fatalities captured in the National Poison Data System to data derived from US death certificate literal text. Pharmacoepidemiol Drug Saf. 2019;28(10):1377–85. https://doi.org/10.1002/pds.4869 .
doi: 10.1002/pds.4869
Palmer A, Higgs P, Scott N, Agius P, Maher L, Dietze P. Prevalence and correlates of simultaneous, multiple substance injection (co-injection) among people who inject drugs in Melbourne. Aust Addict. 2021;116(4):876–88. https://doi.org/10.1111/add.15217 .
doi: 10.1111/add.15217
White WL, Kelly JF. Alcohol/Drug/Substance “Abuse”: the history and (Hopeful) demise of a pernicious label. Alcohol Treat Q. 2011;29(3):317–21. https://doi.org/10.1080/07347324.2011.587731 .
doi: 10.1080/07347324.2011.587731
Zoorob M. Fentanyl shock: the changing geography of overdose in the United States. Int J Drug Policy. 2019;70:40–6. https://doi.org/10.1016/j.drugpo.2019.04.010 .
doi: 10.1016/j.drugpo.2019.04.010